Enveric Biosciences (ENVB) Reports $2.5M Q3 Net Loss, $5.6M Cash

Enveric reported a Q3 2026 net loss attributable to stockholders of $2.5M versus $3.4M a year earlier; loss per share was $0.57 versus $10.81. Cash was $5.6M at September 30, 2026.Material DetailsContext by AI AnalystThis is a quarterly financial update alongside ongoing preclinical development of…